insights_auto
Why is LWB1 down 9.17%?
Dive Deeperchevron_right
LWB1:FRA
Mesoblast Ltd
€10.90
arrow_downward
-9.17%(-1.10) 1D
Oct 19, 3:25:02 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LWB1...
Open
€10.90
High
€10.90
Low
€10.90
Mkt. cap
1.61B
Avg. vol.
0.00
Volume
0.00
52-wk high
€17.00
52-wk low
€10.90
No. of employees
108
Open
€10.90
High
€10.90
Low
€10.90
Mkt. cap
1.61B
Avg. vol.
0.00
Volume
0.00
52-wk high
€17.00
52-wk low
€10.90
No. of employees
108
News stories
From web sources and news partners
Seeking Alpha
·
7 hours ago
Mesoblast: Ryoncil Helps Fund Rexlemestrocel-L For Back Pain (NASDAQ:MESO)
Kalkine
·
11 hours ago
Mesoblast Limited (ASX:MSB): Ryoncil Revenue, FY26 Results and Cell Therapy Pipeline
Simply Wall Street
·
2 days ago
Will Ryoncil Revenue Growth Change Mesoblast Stock Narrative
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd